bilaterals.org logo
bilaterals.org logo

intellectual property


A new approach on investment
A US-India trade deal will have historic significance, especially if it ushers in a period of strong collaboration to advance a shared bilateral trade agenda and effectively resolves troubles as they arise.
Phase 1 US China trade deal: patent provisions
China agreed to extend patent terms for novel drugs "to compensate for unreasonable delays that occur in granting the patent or during pharmaceutical product marketing approvals."
Blueprint for a human rights impact assessment of the planned comprehensive free trade agreement between EFTA and Mercosur
This study assesses the impact of the EFTA-Mercosur free trade agreement on access to medicines, indigenous rights and women rights.
Big Pharma looks to stem losses after trade deal defeat
The industry is working to get US senators on record in support of including the protections it lost in NAFTA 2.0 in future trade agreements with other countries.
India’s withdrawal from RCEP a breather on many fronts
India’s decision to pull out of RCEP means its policy on access to inexpensive drugs will not be under pressure.
China’s new policy on foreign investment and the security of intellectual property
Proper mandatory licenses will be exempt from claims for expropriation under the China BIT model.
What the amendments to the USMCA mean for Canadian IP law
Many requirements of the original USMCA have already been met by recent changes in Canadian IP legislation, but more amendments will be required to implement the USMCA.
Phase two of US-China trade deal will be more challenging and less transparent than phase one
The hard part of the trade dispute will cover long-standing issues relating to intellectual property violations and forced technology transfer by China, as well as subsidization of Chinese industries.
The European Commission is urging Canada to adopt stricter piracy rules
Canada’s intellectual protection rights system was also slammed for being too clement.
India speeding up FTA talks with Switzerland, Norway, Iceland
India is making efforts to speed up free trade negotiations with the EFTA countries comprising Switzerland, Norway, Iceland and Leichtenstein in parallel with its discussions with the European Union on a similar pact.
The US-China trade deal phase two – digital trade, intellectual property, cyber intrusions, and a bilateral investment treaty
The phase two agreement is to be digitally focused and could include a US-China bilateral trade agreement.
Trump administration considers loosening drug protections in USMCA
Generic versions of biologic drugs could come to market faster.
US-UK trade leak: US seeks changes to patents and GIs
Confidential documents from trade negotiations between the UK government and the US detail the US position regarding IP provisions.
China to raise penalties on IP theft in trade war compromise
China said it will raise penalties on violations of intellectual property rights in an attempt to address one of the sticking points in trade talks with the US.
China, EU reach ’hallmark’ bilateral trade GI agreement: MOFCOM
This is the first comprehensive, high-level bilateral agreement China has ever signed with foreign businesses to protect geographic indication.
New rules on IP rights and e-commerce to be set under RCEP free trade agreement
A common set of rules on intellectual property (IP) and e-commerce and a new scope of trade for telecommunication services are among some of the expected benefits that will arise from the RCEP agreement when it is signed next year.
Trade ministers of RCEP to hold key meet next week
Trade ministers of the 16-nation RCEP grouping will meet in Bangkok on October 10-12, in what could be the last ministerial before a potential deal is sealed in November.
Don’t trade our lives away in free trade negotiations
To sign the RCEP and start negotiations on a FTA with the US when the Indian economy is on the brink of economic downturn and needs strong domestic policies is a decision that is not in national or public interest.
US farmers’ group says pharma, not dairy, is main obstacle to ratifying USMCA
The National Farmers Union says the new deal’s extended patent protection for new pharmaceuticals must be reduced so that less expensive generic versions of new drugs can be available to consumers sooner.
Intellectual property under the scrutiny of investor-state tribunals
The fact that private arbitral tribunals are increasingly interpreting intellectual property provisionsraises complex issues.